Loading news...
Loading news...
Sanegene Bio raised $110M Series B venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Eli Lilly |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$228M
Top Valuation
-
Sanegene Bio raised $110M in a Series B round.
The round was announced on 12/09/25.